Researchers tested a medicine called infliximab, which is normally used to treat diseases like arthritis. In this study, they ...
A depression drug candidate that’s a key part of Johnson & Johnson’s neuroscience strategy has failed a Phase 3 clinical trial, the latest dose of disappointing news for an emerging class of medicines ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback